We use cookies to give you the best experience possible. By continuing we’ll assume you’re on board with our cookie policy

Pharmaceuticals Report – Tecnoquimicas Profile

The whole doc is available only for registered users
  • Pages: 4
  • Word count: 856
  • Category: Drugs

A limited time offer! Get a custom sample essay written according to your requirements urgent 3h delivery guaranteed

Order Now

Colombia – Pharmaceuticals & Healthcare – 04 Dec 2008 Indigenous Manufacturers SWOT Analysis Strengths TecnoquĂ­micas is a leading domes tic pharmaceutical company in terms of s ales with a large production network of eight manufacturing s ites The company has repres entative agreements with m a n y foreign firms , including Argentina’s Gador, Pharmacia, Recordati and As tellas Weaknesses Its divers e offering — including pet foods , confectionery and pers onal care items — may reduce focus and funds available for developing pharmaceuticals The company is vulnerable to s trengthened bioequivalence rules and competition from foreign generics players Opportunities TecnoquĂ­micas is in the mids t of implementing a 10year inves tment plan Threats TecnoquĂ­micas repres ents over 25 foreign firms , but the US FTA may eas e direct market entry for foreign companies Entry of foreign — es pecially As ian — low-cos t producers threatens the firm’s off-patent product lines Overview TecnoquĂ­micas was founded in Bogotá in 1934, as a family bus ines s focus ing on repres enting national and international companies in Colombia. The company, which is one of the larges t pharmaceuticals firms by s ales in Colombia, claims to manufacture 87% of the products it markets.

In 2005, the company reported a 20% jump in s ales to COP60bn (US$246mn) and had es timated s ales of US$300mn in 2006 and US$350mn in 2007. TecnoquĂ­micas has three production plants in Cali, one of which manufactures oral s olid dos age forms and hous es a R&D facility The JamundĂ­ facility produces s olids and veterinary s teriles , as . well as hous ing a QC laboratory and a raw material warehous e. The Yumbo facility manufactures creams and ointments for cos metics and topical products . T h e company operates s ix dis tribution centres in Colombia. It has opened a creams and efferves cent products plant in Villa Rica for regional unit Tecnofar TQ. Since the 1990s , TecnoquĂ­micas has expanded internationally, focus ing on regional markets . In 1993, it acquired the MK and McK brands from McKes s on Corporation, and began to produce and s ell generics in the Andean region. In July 2008, the company reportedly s igned a deal with the IFC, the World Bank’s lending arm, to s ell 10% of its s hares in return for US$25mn to fund future expans ion in Central and South America with a particular focus on the Andean region.

Product Portfolio Bes ides pharmaceuticals , the company is active in the pers onal care, infant nutrition, confectionery, hous ehold products , veterinary and telecommunications s egments . TecnoquĂ­micas ‘ large pharmaceutical offering includes generic pres cription drugs , pers onal care products and animal health products . Starting with an agreement with Bayer for Alka-Seltzer in 1941, the company now repres ents 24 companies in Colombia, including Argentina’s Gador, Italy’s Recordati and Japan’s As tellas . In 1986, TecnoquĂ­micas acquired Merck & Co’s Colombian pharmaceuticals plant. TecnoquĂ­micas repres ented the US drug major in the country until 1996. TecnoquĂ­micas is a leader in the Colombian hos pital drugs s egment and the ins titutional market. T h e company’s generic anti-infectives portfolio runs to 37 products . The company fields 28 cardiovas cular generics , 13 central nervous s ys tem (CNS) drugs , 19 mus culo-s keletal products , 13 alimentary/metabolis m preparations and nine res piratory pres entations . Contacts TecnoquĂ­m icas C alle 23 7-39 C ali Tel: +57 (2) 882 5555 www.tecnoquim icas.com .co Leading Drug Products Flucanazole Lipicare (atorvastatin) Sim vastatin C rem a No. 4 Enalapril Glim epiride Fluoxetine TecnoquĂ­micas

Recent Activity TecnoquĂ­micas has announced plans to inves t s ome COP25bn (US$10mn) in 2006, principally on expanding and upgrading its production facilities and offices . The JamundĂ­ facility — which produces oral s olid forms for human us e — and the Villa Rica unit will attract a major s hare of the new s pending. Senior company s ources als o comment that regional expans ion will remain a priority The company has grown its s ales in Ecuador by s ome 25% s ince 2002, and claims to be . the market leader in terms of units s old in the country In 2007, the company s aid it aimed to . increas e s ales there to US$20mn by year-end. The firm entered Peru in early 2006. TecnoquĂ­micas has vigorous ly protes ted an FTA with the US, principally oppos ing new IP provis ions . The company markets a number of copies of patented pharmaceuticals , which has brought it into conflict with R&D-bas ed multinationals in the pas t. Nevertheles s , it has s trong potential in the field of generics , although the entry of low-cos t As ian producers could intens ify competitive pres s ures in the coming years . This material is protected by international copyright laws , and us e of this is s ubject to our Terms & Conditions . © 2012 Bus ines s Monitor International Ltd

Related Topics

We can write a custom essay

According to Your Specific Requirements

Order an essay
Materials Daily
100,000+ Subjects
2000+ Topics
Free Plagiarism
All Materials
are Cataloged Well

Sorry, but copying text is forbidden on this website. If you need this or any other sample, we can send it to you via email.

By clicking "SEND", you agree to our terms of service and privacy policy. We'll occasionally send you account related and promo emails.
Sorry, but only registered users have full access

How about getting this access

Your Answer Is Very Helpful For Us
Thank You A Lot!


Emma Taylor


Hi there!
Would you like to get such a paper?
How about getting a customized one?

Can't find What you were Looking for?

Get access to our huge, continuously updated knowledge base

The next update will be in:
14 : 59 : 59